Implications of updated staging system for p16+ oropharyngeal squamous cell carcinoma: Is valuable prognostic information being omitted?

Head Neck. 2023 Aug;45(8):2079-2086. doi: 10.1002/hed.27436. Epub 2023 Jun 22.

Abstract

Background: This study characterized whether the updated AJCC 8th edition nodal staging system for p16+ oropharyngeal squamous cell carcinoma (OPSCC) resulted in the loss of prognostic value.

Methods: The NCDB was queried for patients with node-positive p16+ OPSCC. The prognostic impact of nodal size, nodal quantity, nodal laterality, and extracapsular extension (ECE) on overall survival (OS) was assessed.

Results: In the clinical cohort, inferior 5-year OS was observed in patients with more than one positive lymph node (p < 0.001; 82% vs. 86%), ECE (p < 0.001; 82% vs. 75%), or nodal size >6 cm (p < 0.001; 66% vs. 82%). In the pathologic cohort, inferior 5-year OS was observed in patients with > four positive lymph nodes (p < 0.001; 76% vs. 90%), ECE (p < 0.001; 83% vs. 92%), or largest nodal size >6 cm (p < 0.001; 81% vs. 89%).

Conclusions: Simplifications in the current p16+ OPSCC staging system led to loss of prognostic information in nodal staging.

Keywords: American Joint Committee on Cancer (AJCC); human papilloma virus (HPV); oropharyngeal cancer; p16; staging.

MeSH terms

  • Extranodal Extension
  • Head and Neck Neoplasms* / pathology
  • Humans
  • Neoplasm Staging
  • Oropharyngeal Neoplasms* / pathology
  • Papillomavirus Infections* / pathology
  • Prognosis
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck / pathology